300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Cryptocurrency
Digital Media
Oil and Gas
Film
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Software
Facebook
Blockchain
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Armenia
Colombia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
New Zealand
Moldova
Seychelles
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Bangladesh
Cyprus
Qatar
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Hungary
Italy
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Slovenia
Mongolia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Medical Startup Investors in Finland (November 2026)

The most active venture capital funds and angel investors investing in Finland Medical startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Finland Medical startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Business Finland
VC Fund
9 Finland, United States, United Kingdom Grant, Seed, Debt Financing Software, SaaS, Biotechnology $52k–$6.6M
Lifeline Ventures
VC Fund
7 Finland, United States, United Kingdom Seed, Series A, Venture - Series Unknown Software, Health Care, Artificial Intelligence $430k–$22M
Finnvera Venture Capital
VC Fund
7 Finland, United States, Chile Seed, Venture - Series Unknown, Series A Software, Health Care, Information Technology $228k–$23M
Voima Ventures
VC Fund
6 Finland, Sweden, Norway Seed, Pre-Seed, Series A Biotechnology, Health Care, Artificial Intelligence $464k–$30M
Innovestor
VC Fund
5 Finland, Sweden, Denmark Seed, Venture - Series Unknown, Pre-Seed Software, Health Care, Information Technology $204k–$5.1M
Maki.vc
VC Fund
4 Finland, Norway, Denmark Seed, Series A, Pre-Seed Software, E-Commerce, Information Technology $578k–$37M
Icebreaker.vc
VC Fund
4 Finland, Sweden, Estonia Pre-Seed, Seed, Series A Software, Information Technology, Artificial Intelligence $110k–$25M
Karolinska
VC Fund
3 Sweden, Denmark, United States Venture - Series Unknown, Seed Biotechnology, Health Care, Pharmaceutical $2.1M–$10M
Novartis Venture Fund
VC Fund
3 United States, Switzerland, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $5.1M–$107M
Reaktor Ventures
VC Fund
3 Finland, Germany, United States Seed, Pre-Seed, Series A Software, Internet, E-Commerce $151k–$6.8M
Springvest
VC Fund
3 Finland Series A, Venture - Series Unknown, Seed Biotechnology, Health Care, Medical $1.6M–$53M
StartUp Health
VC Fund
3 United States, Canada, United Kingdom Seed, Venture - Series Unknown, Pre-Seed Health Care, Medical, Wellness $20k–$15M
Tesi
VC Fund
3 Finland, United States, Switzerland Series A, Series B Software, Manufacturing, Information Technology $2.4M–$46M
Novo Holdings
VC Fund
3 United States, Denmark, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $9.5M–$135M
Butterfly Ventures
VC Fund
3 Finland, Sweden, Norway Seed, Pre-Seed, Venture - Series Unknown Software, Health Care, Information Technology $110k–$6M
M Ventures
VC Fund
3 United States, United Kingdom, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2.4M–$100M
Nordic Science Investments
VC Fund
3 Finland, Sweden, Germany Seed, Pre-Seed, Series A Biotechnology, Medical, Health Diagnostics $373k–$34M
Samsung Venture Investment
VC Fund
2 South Korea, United States, India Series A, Series B, Seed Information Technology, Artificial Intelligence, Software $83k–$25M
Vesalius Biocapital Partners
VC Fund
2 Belgium, Germany, The Netherlands Series A, Series B, Series C Biotechnology, Health Care, Medical $3.9M–$100M
University of Helsinki
VC Fund
2 Finland, Luxembourg, United States Seed, Series A, Pre-Seed Medical, Health Care, Biotechnology $54k–$34M
Nuard Ventures
VC Fund
2 Finland, Germany, United States Seed, Angel, Pre-Seed IaaS, Video, Gaming $159k–$680k
Sandwater
VC Fund
2 Norway, Germany, Finland Series A, Venture - Series Unknown, Series B Manufacturing, Medical, AgTech $4.7M–$35M
Jyri Engestrom
Angel
2 United States, Finland, Spain Seed, Pre-Seed, Series A Software, Apps, Internet $600k–$20M
Metsola Ventures
VC Fund
2 Finland Series A, Pre-Seed Medical, mHealth, Automotive $2.2M–$5.4M
Anssi Vanjoki
Angel
2 Finland Angel, Series A Medical, Hardware, Health Care
Cascara Ventures
VC Fund
2 Germany, Finland, The Netherlands Series A, Seed, Series B Health Care, Biotechnology, Medical Device $2M–$7.9M
Inventure
VC Fund
2 Finland, Sweden, United States Seed, Series A, Series B Software, Information Technology, Artificial Intelligence $549k–$25M
Asko Schrey
Angel
2 Finland Venture - Series Unknown, Seed, Angel Software, Artificial Intelligence, FinTech
Capricorn Partners
VC Fund
1 Belgium, United States, The Netherlands Series A, Series B Biotechnology, Health Care, Software $3.3M–$45M
MVM Life Science Partners
VC Fund
1 United States, United Kingdom, Switzerland Series B, Series C, Venture - Series Unknown Health Care, Medical, Biotechnology $7M–$68M
HTGF (High-Tech Gruenderfonds)
VC Fund
1 Germany, Switzerland, United States Seed, Series A, Venture - Series Unknown Software, Biotechnology, Health Care $680k–$31M
Korpun Siemen
VC Fund
1 Finland Seed, Angel Software, Marketing, Information Technology $480k–$1.3M
Metaplanet
VC Fund
1 United States, United Kingdom, Estonia Seed, Series A, Series B Artificial Intelligence, Software, Machine Learning $1.7M–$62M
Jukka Tapaninen
Angel
1 Finland Seed Medical, Software, Education
Way to Wellville
VC Fund
1 United States, Finland Series B, Venture - Series Unknown, Series A Software, Medical, Health Care $1.2M–$15M
Sunstone Life Science Ventures
VC Fund
1 Denmark, Sweden, Switzerland Series A, Series B, Series C Biotechnology, Health Care, Medical $4.1M–$63M
Visionplus
VC Fund
1 Finland, United States, United Kingdom Seed, Venture - Series Unknown, Series A Software, Information Technology, Internet $87k–$14M
Debiopharm Innovation Fund
VC Fund
1 United States, Switzerland, France Series A, Seed, Pre-Seed Health Care, Biotechnology, Software $317k–$25M
SHS Capital
VC Fund
1 Germany, Switzerland, France Venture - Series Unknown, Series B, Series C Health Care, Medical Device, Medical $5.3M–$60M
Inveni Capital
VC Fund
1 Finland, United Kingdom Venture - Series Unknown Medical, Health Care, Biotechnology $3.4M–$11M
Athensmed
VC Fund
1 Finland, Switzerland Seed, Series A Health Care, Health Diagnostics, Medical $1.1M–$4.3M
Ascend Capital Partners
VC Fund
1 Finland, Israel, Austria Series A, Seed, Series B Health Care, Software, Medical Device $1.5M–$12M
XR Invest
VC Fund
1 Finland, United States Series A, Series B, Series C Medical Device, Sensor, Medical
Ali Omar
Angel
1 Finland, United States, Estonia Seed, Pre-Seed, Angel Software, Artificial Intelligence, SaaS $57k–$2.2M
Noaber
VC Fund
1 The Netherlands, Israel, Germany Seed, Series A, Pre-Seed Health Care, Medical, Fitness $423k–$20M
Cor Group
VC Fund
1 Finland Seed, Pre-Seed, Series A Health Care, Medical, Biotechnology $2.3M–$8.7M
Marten Mickos
Angel
1 Finland, United States, Sweden Seed, Series A, Convertible Note Software, Enterprise Software, Internet $550k–$10M
Hadean Ventures
VC Fund
1 Sweden, Norway, Austria Series A, Series B, Venture - Series Unknown Biotechnology, Health Care, Medical $2M–$79M
Unifund
VC Fund
1 Finland Software, Collaboration, Management Consulting
Nordea
VC Fund
1 Finland, Sweden, Norway Debt Financing, Seed FinTech, Financial Services, Banking
Access all 131 investors in Finland Medical startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Business Finland
VC Fund · Helsinki, Southern Finland, Finland · 9 investments in Finland Medical startups, 15 in the past 12 months

Business Finland finances business R&D projects and public research projects at universities, research institutes and universities of applied sciences. Read more about R&D and business funding.

Show more...

Investment focus

  • Industry: Software, SaaS, Biotechnology
  • Stage:Grant, Seed, Debt Financing
  • Geography: Finland, United States, United Kingdom

Investor stats

  • Total investments: 247
  • Round size: Seed $137k–$3.5M; Grant $52k–$6.6M; Debt Financing $252k–$6.5M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • STRGY AI — The strategy was never the problem. The evidence was correct, sitting in someone's hands, and it died anyway because nothing in the organization was built to carry that evidence from where it was seen to where it could be acted on, and keep it alive long enough to matter. Not a bad plan. Not bad people. A structural gap between signal andauthority that every existing tool — decks, dashboards, status meetings — is too static and too easy to ignore to actually close.STRGY exists because that gap is the default state of every organization above a certain size, and closing it has always required either a heroic individual repeating themselves for years or luck (the corporate pilot needed one person to remember "do not drop this" at the right moment, and no one did). That's not a strategy problem to solve with a better framework — it's an infrastructure problem. You need something that holds the signal, doesn't forget it, doesn't get bored repeating it, and resurfaces it automatically the moment the gap between evidence and action starts to widen. That's what a human can't do reliably at scale, and what software with real memory can.
  • Coolbrook — Coolbrook is a manufacturer of naphtha cracking-based reactors. Their technology is intended to replace the conventional steam cracker furnace in existing and new olefins plants, enabling petrochemical clients to get improved product yield and lower energy consumption.
  • Solar Foods — Solar Foods is a food-tech startup that specializes in testing a technology that uses electricity to produce hydrogen which is combined with carbon dioxide, water, vitamins, and minerals to feed and grow microbial biomass that can be used as edible protein. The industrial biotech startup develops a protein called Solein, a nutritious, sustainablesubstitute for animal-derived proteins. Solein is created using elements from the air—CO2, water, nitrogen—and electricity. This single-cell protein is cultivated through gas fermentation, essentially deriving edible calories from hydrogen-oxidizing microbes.
Show all investments...

Lifeline Ventures
VC Fund · Helsinki, Southern Finland, Finland · 7 investments in Finland Medical startups

Lifeline Ventures is one of the world's highest performing venture funds. Founded by serial entrepreneurs, Lifeline partners closely with resilient founders from day one — supporting them with funding, talent, and everything it takes to build category-leading companies. The fund is sector-agnostic and seeks to make inception to Series A investments. Lifeline Ventures was founded in November 2009 and is based in Helsinki, Finland.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Finland, United States, United Kingdom

Investor stats

  • Total investments: 208
  • Round size: Seed $580k–$5.4M; Series A $2.8M–$22M; Venture - Series Unknown $430k–$11M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: Likely actively investing — fresh fund, raised $464M in 2025

Portfolio highlights

  • Verda — Verda provides a full-stack AI cloud platform for the development, training, and deployment of AI models. Its services include GPU instances, instant clusters, serverless containers, managed storage, and other cloud infrastructure powered by NVIDIA hardware. Verda also operates an AI Lab focused on large-scale training, inference optimization, reinforcement learning, and AI systems engineering. Its platform serves AI developers and organizations across the full AI lifecycle, from prototyping to scalable inference.
  • Thor Dynamics — Headquartered in Orlando, Florida, with a European base in Finland, Thor Dynamics specializes in directed energy systems for defense against drones and drone swarms. The company’s innovative solutions are available worldwide to protect critical infrastructure and enhance national security. Laser Armor™ is a complete directed energy counter-dronesolution. Utilizing advanced radar and optical systems it can detect, track, and target hostile targets. High-power directed energy from Thor’s Laser Engines then eliminates the threat in seconds. Multiple safety systems ensure accurate target identification and minimal collateral damage.
  • Coherence Quantum — Coherence Quantum is a quantum hardware company that creates integrated cryogenic signaling and control platforms designed for solid-state quantum computers.
Show all investments...

Finnvera Venture Capital
VC Fund · Kuopio, Eastern Finland, Finland · 7 investments in Finland Medical startups

Finnvera makes direct investments in early-stage enterprises through Seed Fund Vera Ltd. Finnvera's goal is to cover shortcomings existing on the market between product development funding and private equity investments. Finnvera does not compete with private financiers; instead, it strives to supplement the financial market. Finnvera's investments enable, start and accelerate growth and internationalisation among investment targets. Enterprises are developed to make them attractive targets for further financing by other investors and industrial actors. Investments are made in technology enterprises at an early stage and in technology-intensive or innovative service enterprises that have potential for developing into international growth enterprises. Finnvera is also known as a specialised financing company owned by the State of Finland. It provides its clients with loans, guarantees, venture capital investments and export credit guarantees.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: Finland, United States, Chile

Investor stats

  • Total investments: 96
  • Round size: Seed $250k–$2.3M; Series A $1.8M–$23M; Venture - Series Unknown $228k–$11M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • ARAUCO — ARAUCO is a diversified global company in the forestry industry. They use world-class technologies and processes throughout the value chain. They are present in the forestry, pulp, timber, panels and renewable energy businesses.
  • eMabler — EMabler is an EV charging infrastructure software company that develops an API-first platform used by businesses to operate, manage, and scale electric vehicle charging networks. It provides a centralized system for charge point management, billing, pricing, roaming, and energy optimization, allowing operators to control large networks of EVchargers from a single platform. The software connects charging hardware with business systems such as CRM, payment, and energy management tools through open APIs and a large library of integrations. The company focuses on enabling enterprises, such as energy utilities, parking operators, and retail businesses, to embed EV charging directly into their existing services and digital platforms rather than building standalone charging systems. This includes white-label solutions where charging is integrated into a company’s own app or customer experience under its brand.
  • CHAOS — At CHAOS, we strive to democratize data and harness the power of AI and cutting-edge technology, delivering transformative location insights that empower decision-makers to design more liveable cities- sustainable, human-centered where the quality-of-life soars.
Show all investments...

Voima Ventures
VC Fund · Helsinki, Southern Finland, Finland · 6 investments in Finland Medical startups, 7 in the past 12 months

Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics, software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Finland, Sweden, Norway

Investor stats

  • Total investments: 62
  • Round size: Seed $1M–$5.9M; Pre-Seed $464k–$2.1M; Series A $3.9M–$30M
  • Lead/follow: 65% lead, 35% follow
  • Last fund: Likely still investing — raised $108M in 2023

Portfolio highlights

  • Reduciner — Reduciner's vision to turn industrial CO₂ emissions from a liability into a valuable resource. Its technology converts captured carbon dioxide and biochar into valuable feedstocks such as carbon monoxide and activated carbon, enabling circular carbon use in emissions-intensive industries. Reduciner combines strong scientific expertise withindustrial applicability across sectors such as cement, steel, and chemicals. Its electricity-driven process allows industries to reduce emissions without major changes to existing infrastructure, offering a resilient and cost-competitive way to reduce carbon dependency while creating new value from CO₂ emissions.
  • TheStorage — Flexible industrial heat electrification and scalable energy storage. TheStorage offers cost efficient, sustainable grid scale energy storage that can discharge heat, steam or CHP.
  • Aventix — Aventix is a bioanalytics/life-science instrumentation company that develops sensor-based laboratory tools.
Show all investments...

Innovestor
VC Fund · Helsinki, Southern Finland, Finland · 5 investments in Finland Medical startups

Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Venture - Series Unknown, Pre-Seed
  • Geography: Finland, Sweden, Denmark

Investor stats

  • Total investments: 98
  • Round size: Seed $477k–$4.5M; Pre-Seed $204k–$2M; Venture - Series Unknown $529k–$5.1M
  • Lead/follow: 55% lead, 45% follow
  • Last fund: Likely still investing — raised $33M in 2023

Portfolio highlights

  • Khoy — Khoy Company is a furniture company focused on designing and developing comfortable, user-friendly, and sustainable sofa beds. It combines functionality, comfort, and modern design to create versatile furniture for everyday living, with an emphasis on sustainability and space efficiency.
  • AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
  • Bahn Express — Bahn Express is a global car transportation company that supports independent contractors while offering quick and easy auto shipping throughout Europe.
Show all investments...

Maki.vc
VC Fund · Helsinki, Southern Finland, Finland · 4 investments in Finland Medical startups

We partner with deep tech and brand-driven companies obsessed in challenging category norms. The Nordics are our home, but we take on a global front in spotting the unexpected - from B2B to B2C, with a sweet spot for scientific advances, strong IP, and customer understanding that looks beyond convention. We invest in early stage companies: from their inception to series A and beyond. We share in the vision of founders as champions and challengers, drawing on our experiences from scaling some of the strongest tech companies ourselves.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Finland, Norway, Denmark

Investor stats

  • Total investments: 104
  • Round size: Seed $948k–$8.3M; Pre-Seed $578k–$2.7M; Series A $3.5M–$37M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: Likely still investing — raised $106M in 2024

Portfolio highlights

  • Aavuus — Aavuus is building a global network of ground-based laser stations to detect and track space debris with high precision.
  • Quanscient — Quanscient develops multiphysics simulation software utilizing quantum computing algorithms to improve simulation technology. Its Computer Aided Engineering (CAE) platform integrates a unique combination of cloud-native multiphysics solvers, advanced cloud computing, and future quantum integration. The platform also offers engineers over ahundredfold increase in simulation throughput to enable fully digital R&D processes, addressing complex technology challenges in industries like fusion energy, 6G/7G, advanced semiconductors, biomedical, automotive, and aerospace.
  • Volare — Refining food, beverage and agricultural sidestreams into protein, oil and fertilizers. Sustainable Black Soldier Fly Protein & Oil for Pet Food and Aquafeed from Finland.
Show all investments...

Icebreaker.vc
VC Fund · Helsinki, Southern Finland, Finland · 4 investments in Finland Medical startups

Founded in 2016, Icebreaker has invested in over 50 fast-growing tech startups built by domain expert founders from companies like Rovio, Nordea, Pipedrive, Eniram, IBM and BCG. In addition to the fund, Icebreaker also runs a community of more than 1000 founders and pre-founders with 5+ years of relevant industry experience and the will to start, build or join strong tech companies. With the initial ticket sizes of €150k - 800K Icebreaker provides enough funding for companies to get to a position of strength and avoid post-accelerator limbo without having to resort to disreputable sources of capital and unfriendly deal terms.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Finland, Sweden, Estonia

Investor stats

  • Total investments: 144
  • Round size: Seed $409k–$5.4M; Pre-Seed $110k–$1.3M; Series A $3.1M–$25M
  • Lead/follow: 56% lead, 44% follow
  • Last fund: May invest from a new fund soon — raised $24M in 2021

Portfolio highlights

  • Cachet — Adaptive insurance solutions for micromobility, car-sharing and gig work platforms in 16 countries. Feel in control of risk and handle claims in one system.
  • Oplane — Connect your repo. See and fix your vulnerabilities in minutes. AI-powered threat modeling - no consultants, no weeks of docs.
  • Cota Robotics — Cota Robotics deploys general-purpose robots in retail stores through a Robot-as-a-Service model, integrating with existing environments without requiring changes to store layouts or infrastructure. The company automates shelf replenishment, inbound handling, and order picking using human-in-the-loop teleoperation, with autonomy increasing asdeployment data trains its models.
Show all investments...

Karolinska
VC Fund · Solna, Stockholms Lan, Sweden · 3 investments in Finland Medical startups

Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatest return on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products. Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB. The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced. The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companies Karolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Venture - Series Unknown, Seed
  • Geography: Sweden, Denmark, United States

Investor stats

  • Total investments: 32
  • Round size: Venture - Series Unknown $2.1M–$10M
  • Lead/follow: 34% lead, 66% follow

Portfolio highlights

  • BOOST Pharma — BOOST Pharma is developing BT-101, an off-the-shelf therapy for early intervention in children with severe osteogenesis imperfecta (OI).
  • Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
  • Umecrine Cognition — Umecrine Cognition is a Swedish clinical-stage pharmaceutical company developing a novel class of drugs to treat neurological disorders of the brain.
Show all investments...

Novartis Venture Fund
VC Fund · Basel, Basel-Stadt, Switzerland · 3 investments in Finland Medical startups

Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 247
  • Round size: Series A $5.1M–$81M; Series B $11M–$107M; Series C $9M–$75M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: May invest from a new fund soon — raised $200M in 2009

Portfolio highlights

  • Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
  • Visiogen — Visiogen, Inc. is an ophthalmic medical device company specializing in the development of new vision alternatives for patients with cataracts, with and without presbyopia. As part of this mission, Visiogen created the Synchrony dual optic accommodating *intraocular lens (IOL)* for use in the surgical treatment of these conditions.The device isdesigned to provide patients with near, intermediate and distance vision in a seamless continuum without the need for glasses or contact lenses. To eliminate lens handling during surgery, the Synchrony dual optic IOL is provided in a pre-loaded injector. This patented technology has been approved in Europe with a CE Mark designation and is currently undergoing clinical trials in the United States.
  • Rein Therapeutics — Harnessing fibrosis, unleashing life
Show all investments...

Reaktor Ventures
VC Fund · Helsinki, Southern Finland, Finland · 3 investments in Finland Medical startups

Reaktor Ventures they invest in seed stage companies and helps them to create markets.

Show more...

Investment focus

  • Industry: Software, Internet, E-Commerce
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Finland, Germany, United States

Investor stats

  • Total investments: 60
  • Round size: Seed $151k–$2.1M; Pre-Seed $158k–$1.8M; Series A $1.7M–$6.8M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Valpas — Valpas is the hygiene protocol that reassures your future guests and keeps your hotel clean from the most uncontrollable: bed bugs
  • allies.digital — Allies is a match-making platform curating businesses with IT-, digital and creative agencies. No more miss-matches when buying IT & creative services.
  • StarBerry Games — StarBerry Games GmbH is a mobile games company based in Berlin, Germany. The company develops free-to-play casual mobile games and is best known for its games Merge Mayor and Idle Coffee Corp.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Springvest
VC Fund · Helsinki, Southern Finland, Finland · 3 investments in Finland Medical startups

Springvest is a listed growth equity investor connecting Finnish technology companies with both domestic and international capital. We typically raise €5–12 million rounds from our Finnish investor base and lead larger rounds of up to €50 million together with international co-investors. We remain a committed minority shareholder in every company we back.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Venture - Series Unknown, Seed
  • Geography: Finland

Investor stats

  • Total investments: 25
  • Round size: Seed $1.6M–$7.6M; Series A $3.6M–$53M; Venture - Series Unknown $4.7M–$31M
  • Lead/follow: 72% lead, 28% follow

Portfolio highlights

  • Desentum — Allergen immunotherapy that is effective, safe, patient-friendly and approved by the regulatory authorities.
  • Volare — Refining food, beverage and agricultural sidestreams into protein, oil and fertilizers. Sustainable Black Soldier Fly Protein & Oil for Pet Food and Aquafeed from Finland.
  • CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
Show all investments...

StartUp Health
VC Fund · New York, New York, United States · 3 investments in Finland Medical startups

Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots

Show more...

Investment focus

  • Industry: Health Care, Medical, Wellness
  • Stage:Seed, Venture - Series Unknown, Pre-Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 407
  • Round size: Seed $100k–$3.5M; Pre-Seed $20k–$854k; Venture - Series Unknown $150k–$15M
  • Lead/follow: 3% lead, 97% follow
  • Last fund: May invest from a new fund soon — raised $31M in 2018

Portfolio highlights

  • AvoMD — AvoMD is reimagining clinical decision support with interactive point-of-care software, available standalone and via EHR integrations, and seamless content building tools.
  • Hidoc Consult — Hidoc Consult: Boost your well-being with free consultations, 24/7 access to quality healthcare, complete privacy, user-friendly, and a trusted network of HCPs
  • NEXT Life Sciences — NEXT Life Sciences is developing the revolutionary Plan A™ procedure to bring the only scientifically proven technology in the category - Vasalgel® - to market.
Show all investments...

Tesi
VC Fund · Helsinki, Southern Finland, Finland · 3 investments in Finland Medical startups

Finnish Industry Investment Ltd is a government-owned investment company. It invests the proceeds accrued from the privatisation of state-owned companies in stimulating the growth and internationalisation of Finnish businesses. Finnish Industry Investment invests in venture capital funds and directly in growth companies, together with private co-investors. The targets are in all sectors. Capital investments are needed for financing the growth of investee companies, and for spin-offs, major industrial investments, and sector and corporate restructurings. The investments of Finnish Industry Investment amount to over MEUR 570

Show more...

Investment focus

  • Industry: Software, Manufacturing, Information Technology
  • Stage:Series A, Series B
  • Geography: Finland, United States, Switzerland

Investor stats

  • Total investments: 154
  • Round size: Series A $2.4M–$46M; Series B $3.1M–$40M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: May invest from a new fund soon — raised $177M in 2017

Portfolio highlights

  • Vexlum — VECSELs Novel semiconductor lasers for high-impact applications in quantum technology, medicine and semiconductor industry.
  • Verda — Verda provides a full-stack AI cloud platform for the development, training, and deployment of AI models. Its services include GPU instances, instant clusters, serverless containers, managed storage, and other cloud infrastructure powered by NVIDIA hardware. Verda also operates an AI Lab focused on large-scale training, inference optimization, reinforcement learning, and AI systems engineering. Its platform serves AI developers and organizations across the full AI lifecycle, from prototyping to scalable inference.
  • Kasvu Therapeutics — Kasvu develops first and best-in-class small molecule neuroplastogens for diseases where neuronal connectivity is altered
Show all investments...

Novo Holdings
VC Fund · Hellerup, Hovedstaden, Denmark · 3 investments in Finland Medical startups

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Denmark, United Kingdom

Investor stats

  • Total investments: 415
  • Round size: Series A $9.5M–$133M; Series B $15M–$135M; Series C $35M–$118M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — raised $165M in 2018

Portfolio highlights

  • Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
  • SCHOTT Poonawalla — SCHOTT Poonawalla is a manufacturer of pharmaceutical containers, made of neutral glass tubing. The company provides parenteral packaging systems crafted from tubular glass, serving the pharmaceutical industry with a broad range of products including vials, pre-fillable syringes, ampoules, and cartridges.
  • Vantia Therapeutics — Vantia Therapeutics is an emerging pharmaceutical company developing novel, small molecule drugs targeting large areas of unmet medical need. Its strong clinical pipeline includes VA106483 for nocturia and VA111913 for dysmenorrhoea, which directly target indications that together affect many millions of people, are poorly treated and representbillion dollar markets. Vantia's strategy is to develop its proprietary drug candidates through Phase II clinical testing and then commercialise through partnerships. The Company was founded in 2008 and is backed by specialist life science investors Novo A/S, SV Life Sciences and MVM Life Science Partners.
Show all investments...

Butterfly Ventures
VC Fund · Oulu, Oulu, Finland · 3 investments in Finland Medical startups

Butterfly Ventures is a seed-stage focused VC in the Nordics, investing in deep tech, hardware, and hardware interfacing software. The company prefers to get involved with companies early on; 80% of Butterfly Ventures portfolio companies don't have any revenue at the time of their entry. Butterfly Ventures was founded in 2012 and ever since then it has been one of the most active early stage VCs in the region. The company has offices in Oulu, Helsinki and Stockholm.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: Finland, Sweden, Norway

Investor stats

  • Total investments: 91
  • Round size: Seed $224k–$2.2M; Pre-Seed $110k–$4.3M; Venture - Series Unknown $1.2M–$6M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely still investing — raised $49M in 2022

Portfolio highlights

  • DREV — DREV is a cleantech company manufacturing contamination control solutions for the world’s most advanced manufacturing facilities.
  • Zenniz — Zenniz is an ITF approved game tracking solution that provides real-time info, such as automated line calling, stroke and serve speeds, shot charts, match statistics and more. Players and coaches at all levels can use Zenniz on and off the court to help improve their game. For tennis clubs, Zenniz is an easy and cost-effective way to upgrade to thenext level. Due to a new, innovative sensor technology, they’ve been able to keep the cost to a minimum, making Zenniz accessible for all clubs, coaches and players.
  • Polar Light Technologies — Polar Light Technologies focuses on developing the next generation of Nano and micro LED technology.
Show all investments...

M Ventures
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 3 investments in Finland Medical startups

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 190
  • Round size: Seed $2.4M–$24M; Series A $5.8M–$56M; Series B $13M–$100M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Mueon — semiconductor-based systems for AI and hyperscale computing
  • Nouscom — Nouscom is a next-generation immunotherapy company developing genetic cancer vaccines and oncolytic viruses..
  • iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
Show all investments...

Nordic Science Investments
VC Fund · Helsinki, Southern Finland, Finland · 3 investments in Finland Medical startups

We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Diagnostics
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Finland, Sweden, Germany

Investor stats

  • Total investments: 19
  • Round size: Seed $373k–$4.6M; Pre-Seed $380k–$837k; Series A $2.9M–$34M
  • Lead/follow: 79% lead, 21% follow
  • Last fund: Likely still investing — raised $34M in 2024

Portfolio highlights

  • MuRay — MuRay develops non-destructive 3D inspection technology powered by an artificial muon beam that is generated on demand via a compact laser-plasma accelerator. The startup's value proposition centers on replacing slow cosmic muon tracking with an active, rapid accelerator platform that yields 100x deeper material penetration than conventional X-rays. Its technology enables high-resolution, internal structural analysis of massive, high-density elements across industrial aerospace, automated security, and medical imaging applications.
  • mu-ray.tech — MuRay Tech generates a controlled muon beam to image inside solid metal and 3D printed pieces. Non-destructively. In minutes.
  • Kasvu Therapeutics — Kasvu develops first and best-in-class small molecule neuroplastogens for diseases where neuronal connectivity is altered
Show all investments...

Samsung Venture Investment
VC Fund · Seocho, Seoul-t'ukpyolsi, South Korea · 2 investments in Finland Medical startups, 9 in the past 12 months

Samsung Venture Investment is plays the role of driving the discovery and development of new businesses and technologies.

Show more...

Investment focus

  • Industry: Information Technology, Artificial Intelligence, Software
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, India

Investor stats

  • Total investments: 147
  • Round size: Seed $83k–$4.1M; Series A $1.7M–$25M; Series B $2.8M–$23M
  • Lead/follow: 31% lead, 69% follow

Portfolio highlights

  • MangoBoost — Data Processing Unit (DPU) is a next-generation server accelerator designed to orchestrate various intra-server devices (e.g., CPU, GPU, SSD, NPU, NIC). By maximizing the datacenter’s overall performance and cost efficiency, DPU is now considered as the most important HW/SW solution to realize the next-generation extreme-scale AI serverinfrastructure. However, despite its critical necessity from the datacenter and AI infrastructure, there is no market-leading DPU solution which can meet the customer’s actual demand due to its HW/SW complexity and the application/model heterogeneity. MangoBoost is currently the world’s most highly recognized DPU startup located in US and Korea. We provide the world’s most advanced and flexible DPU HW/SW solutions in order to fully satisfy the needs of various customers. Our DPU HW is fully composable by integrating its rich set of DPU features to construct our customer-optimal DPUs. At the same time, our DPU SW enables to seamlessly deploy the solution to any customer environment. As a result, our DPU solutions are considered very promising to realize the next-generation AI/datacenter infrastructure, and thus they are currently evaluated at various global-leading companies. MangoBoost was founded in early 2022 to commercialize 7 year of top-tier DPU research outcomes achieved at Seoul National University (e.g., many full-system DPU prototypes, many ISCA/MICRO/ASPLOS/OSDI/ATC papers). The current team consists of 45+ system engineers including ~20 top-tier PhDs from Carnegie Mellon University, Seoul National University, POSTECH, U Toronto, and ~20 industry experts from Intel, Microsoft, Samsung, and Naver.
  • AIDIN ROBOTICS — AIDIN ROBOTICS redefine interactive sensors. Advanced force/torque sensor, proximity sensor for human-robot collaboration.
  • Aim Intelligence — Leading AI Security & Safety Solutions Provider - Specializing in AI Risk Detection, Mitigation, and Elimination through Advanced Red Teaming and Defensive Systems | Leading provider of AI Security, Safety, and Compliance solutions
Show all investments...

Vesalius Biocapital Partners
VC Fund · Strassen, Luxembourg, Luxembourg · 2 investments in Finland Medical startups

Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception. With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financing rounds. Their companies are based in Europe allowing easy interaction with management. They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Belgium, Germany, The Netherlands

Investor stats

  • Total investments: 62
  • Round size: Series A $3.9M–$31M; Series B $4.4M–$26M; Series C $7.8M–$100M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely still investing — raised $103M in 2023

Portfolio highlights

  • Nutrium — Nutrium is the most up-to-date nutrition software for dietitians and nutritionists to manage their nutrition business with nutritional assessment, meal planning and progress tracking.
  • RougeTx — RougeTx is a Netherlands-based biotech developing first-in-class small-molecule therapies for vascular diseases caused by pericyte dysfunction. Its lead candidate, RTX-001, targets hereditary haemorrhagic telangiectasia (HHT), an inherited disorder involving fragile blood vessels and recurrent bleeding.
  • ENYO Pharma — ENYO Pharma is a biopharmaceutical company incorporated in Jan, 2014, by four scientists of the Infectiology Research Center in Lyon, France, and three seeding partners (2 privates and 1 public).The company is based in the Infectiology Center of Lyonbiopôle in Lyon, France and maintains tight collaborations with the seminal Inserm team and theBSL4 laboratory Inserm-Jean Mérieux.ENYO Pharma has licensed several Inserm patents issued from the discoveries of the founding scientists and developed a unique platform for the identification of intracellular therapeutic targets and molecules.The company is developing treatments against the most important viruses and is thriving to become a global leader in anti-virals. Research and Development is currently focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company plans to conduct its molecules to Phase II clinical trials.
Show all investments...

University of Helsinki
VC Fund · Helsinki, Southern Finland, Finland · 2 investments in Finland Medical startups

The University of Helsinki has the widest range of disciplines in Finland. It was established in Turku in 1640, but was transferred to Helsinki in 1828. The number of faculties is eleven. There are 35,000 degree students and 7,900 staff. The number of degrees taken each year is an average 5,000, of which about 470 are doctorates. The University concentrates on high-level scientific research and researcher education. Scientific research is also the basis of the teaching provided by the University. The University operations support the development of society, as well as business and industry. University representatives offer their competencies for the benefit of society through a number of positions of trust and expertise. The results produced by the research and teaching carried out at the University have been widely acclaimed. The University participates in more than half of the national Centres of Excellence in Research, elected by international scientific panels. The University of Helsinki has been invited to be a member of the League of European Research Universities, a co-operation body for the leading European research universities. According to international expert panels, also the teaching provided by the University of Helsinki is of a high European level. The University has strong international connections. It has some 80 co-operation agreements with universities on different continents. The University researchers are in great demand as experts in international scientific communities, meetings and publications. The University is bilingual, but in addition to Finnish and Swedish teaching is also provided in English. Besides Helsinki, the University has operations at 20 localities throughout Finland.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Finland, Luxembourg, United States

Investor stats

  • Total investments: 12
  • Round size: Seed $54k–$7.4M; Pre-Seed $837k–$1.2M; Series A $2.9M–$34M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • Ferrivia — Ferrivia on suomalainen palvelu, joka keskittyy raudanpuutteen ja rautaterveyden mittaamiseen.
  • Avenue Biosciences — From biotechnology tools to therapy discovery and development: Our platform enhances production yield and the quality of your end product.
  • Kasvu Therapeutics — Kasvu develops first and best-in-class small molecule neuroplastogens for diseases where neuronal connectivity is altered
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Nuard Ventures
VC Fund · Helsinki, Southern Finland, Finland · 2 investments in Finland Medical startups

Nuard: Early-stage venture investment expert in gaming, AI, and tech sectors. With 75+ years of industry experience, we offer capital, knowledge, and a powerful network for your startup's success.

Show more...

Investment focus

  • Industry: IaaS, Video, Gaming
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Finland, Germany, United States

Investor stats

  • Total investments: 9
  • Round size: Seed $159k–$680k
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • WARD — WARD is a fantasy sport game, where fans can watch their favourite eSports matches and predict what will happen in real time.WARD is a startup out of Berlin which has created a “pick and predict” real-time prediction smartphone game, where players can win real prizes. People love to watch e-sports. We believe on these occasions they still want tobe able to participate.However, until now no product has offered anything other than the ability to watch. There’s been no way for fans to spectate, participate, analyse and predict the outcomes of their favourite games.
  • MVision AI — AI-powered solutions that automate repetitive tasks, enable efficient radiotherapy workflows, and promote consistency across clinical processes.
  • Polka Dot Studio — Kalian Bisa Memasang Taruhan Online Dengan Sangat Mudah Dan Nyaman Di Situs DEWAHOKI Yang Sudah Resmi Di Indonesia
Show all investments...

Sandwater
VC Fund · Oslo, Oslo, Norway · 2 investments in Finland Medical startups

We are Sandwater. Regeneration of our resources. Vitalizing healthcare & education. Improving life through technology.

Show more...

Investment focus

  • Industry: Manufacturing, Medical, AgTech
  • Stage:Series A, Venture - Series Unknown, Series B
  • Geography: Norway, Germany, Finland

Investor stats

  • Total investments: 24
  • Round size: Series A $8.5M–$24M; Series B $17M–$35M; Venture - Series Unknown $4.7M–$18M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Mantle8 — Using bottom-up exploration and decades of geology experience, we are on a mission to deliver natural hydrogen to the world.
  • CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
  • Alva Industries — Serving industries from aerospace to marine, we deliver high-performance, sustainable motors to drive a cleaner, more efficient future.
Show all investments...

Jyri Engestrom
Angel · San Francisco, California, United States · 2 investments in Finland Medical startups

Jyri Engestrom is based out of Helsinki, Southern Finland and is the Co-Founder and General Partner of Yes VC & General Partner of Lifeline Ventures. Jyri previously worked at Groupon as a Director of Product Management. Jyri Engestrom attended the Lancaster University.

Show more...

Investment focus

  • Industry: Software, Apps, Internet
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Finland, Spain

Investor stats

  • Total investments: 38
  • Round size: Seed $600k–$4.7M; Pre-Seed $3M–$5.5M; Series A $2.8M–$20M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Jow — Jow is a grocery shopping app that simplifies shopping and gives advice of what to eat. This app offers free and simple recipes that adapt to the customer's taste. It automatically creates a customized menu with delicious recipes and fills the cart with all the ingredients necessary for cooking.Jow was founded in 2017 and is headquartered inParis, France.
  • Spell — Operationalizing AI for NLP, Computer Vision, and Speech Recognition has never been easier
  • Orchid Labs — Orchid Labs is an open-source project committed to ending surveillance and censorship on the internet. Orchid uses an overlay network built upon the existing internet, which is driven by a peer-to-peer tokenized bandwidth exchange, creating a more inclusive, liberated internet. Orchid Labs was founded in 2017 by Dr. Steven Waterhouse, Jay Freeman,Brian J. Fox, Gustav Simonsson, and Stephen Bell.
Show all investments...

Metsola Ventures
VC Fund · Espoo, Southern Finland, Finland · 2 investments in Finland Medical startups

Metsola Ventures

Show more...

Investment focus

  • Industry: Medical, mHealth, Automotive
  • Stage:Series A, Pre-Seed
  • Geography: Finland

Investor stats

  • Total investments: 3
  • Round size: Series A $2.2M–$5.4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
  • RoadCloud — Use the worlds most accurate road condition data to your advantage. Real-time hyperlocal road weather data from your road network 24/7.
  • Synoste — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
Show all investments...

Anssi Vanjoki
Angel · Helsinki, Southern Finland, Finland · 2 investments in Finland Medical startups

As Executive Vice President and General Manager of Multimedia, Nokia, Anssi Vanjoki heads a business group that is responsible for developing Nokia Nseries multimedia computers and associated experiences and services. This fast growing segment of consumer electronics will shape our lives in a fundamental way. A highly respected brand authority with over 25 years of marketing experience, Anssi has been a driving force in Nokia's efforts to address the mobile markets. His work has focused on developing Nokia's brand durability, loyalty and continuity, while, at the same time, advancing Nokia's vision of a mobile world. Anssi joined Nokia in 1991 and was named Vice President, Sales, Nokia Mobile Phones, before his promotion in 1994 to Senior Vice President, Nokia Mobile Phones Europe and Africa. In 1998 he was made Executive Vice President, Nokia Mobile Phones Europe and Africa and became a member of the Group Executive Board of Nokia. In addition, in 1999, Anssi took responsibility for Nokia's Digital Convergence Unit and, in 2002, also headed up the Business Unit Management. He was appointed to his present position on January 1st 2004. Prior to joining Nokia, Anssi held a variety of management positions at 3M Corporation. Anssi is the Chairman of the Board of Amer Group, and was a member of the Governing Committee of the European Foundation for Quality Management 2001 - 2003. He is a Knight, 1st Class, of the Order of the White Rose of Finland. Anssi holds a master's degree in economics from the Helsinki School of Economics and Business Administration.

Show more...

Investment focus

  • Industry: Medical, Hardware, Health Care
  • Stage:Angel, Series A
  • Geography: Finland

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • HumanCharger — Discover HumanCharger, a wearable bright light headset designed for convenient daily light exposure. Portable, hands-free and ready in just 12 minutes.
Show all investments...

Cascara Ventures
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 2 investments in Finland Medical startups

96 Normal 0 false false false EN-GB X-NONE X-NONE

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Seed, Series B
  • Geography: Germany, Finland, The Netherlands

Investor stats

  • Total investments: 13
  • Round size: Series A $2M–$7.9M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Fiagon — Fiagon develops clinical navigation systems that reimagine image guidance by improving the function of electromagnetic navigation. Fiagon's systems use electromagnetic tracking matrix algorithms and flexible pointer technology that indicates the position of the instrument used in the CT or MRI image data, allowing physicians to get accurateplanning, improve patient outcomes, and implementation of the operation.
  • Meidrix Biomedicals — Meidrix Biomedicals is a medical biotechnology company that specializes in medical devices for cartilage repair. Meidrix Biomedicals also offers regenerative and biological medical products. Meidrix Biomedicals was founded in 2009 and was headquartered in Bayern, Germany.
  • SurgicEye — SurgicEye designs intra-operative imaging and instrument navigation solutions for surgical procedures. It offers a navigated radio-guided surgery based on the handheld 3-D freehand SPECT imaging technology called the declipse SPECT open surgery, an intraoperative 3D imaging system for invasive sentinel lymph node biopsy called the declipse SPECTLaparascopy, and a mobile SPECT imaging solution with a high resolution on a small footprint called the declipse SPECT imaging probe. The company also advises clients on medical device development, requirement engineering and software specification for medical devices, software development for medical devices, testing of software for medical devices, and support in the design and conduction of clinical studies.Dr. Jörg Traub founded SurgicEye in 2008, with its headquarters in Munich in Germany.
Show all investments...

Inventure
VC Fund · Helsinki, Southern Finland, Finland · 2 investments in Finland Medical startups

Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: Finland, Sweden, United States

Investor stats

  • Total investments: 180
  • Round size: Seed $549k–$6M; Series A $1.3M–$17M; Series B $1.3M–$25M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: Likely still investing — raised $140M in 2022

Portfolio highlights

  • Lassie — Lassie is the first proactive and preventive pet insurance company that wants to help pet owners take better care of their pets
  • Capalo AI — We maximize the value of your energy storage systems. Now and in the future.
  • Algorithmiq — Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.
Show all investments...

Asko Schrey
Angel · 2 investments in Finland Medical startups

Asko Schrey

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, FinTech
  • Stage:Venture - Series Unknown, Seed, Angel
  • Geography: Finland

Investor stats

  • Total investments: 5
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • Zefort — Zefort is a powerful contract management software. Sign, store, share contracts and easily with your team. Set reminders and use a powerful search.
  • ContractZen Governance Suite — ContractZen corporate governance software is ideal for contract management, board meeting management, entity management, e-signature & virtual data room (VDR).
  • ReceiptHero — ReceiptHero: Global digital receipt infrastructure connecting merchants, banks, and consumers. Connect POS systems to banking apps via a single API. Save costs and reduce CO2.
Show all investments...

Capricorn Partners
VC Fund · Leuven, Vlaams-Brabant, Belgium · 1 investments in Finland Medical startups

Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series A, Series B
  • Geography: Belgium, United States, The Netherlands

Investor stats

  • Total investments: 124
  • Round size: Series A $3.3M–$18M; Series B $5.3M–$45M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely actively investing — fresh fund, raised $53M in 2025

Portfolio highlights

  • HighLife — HighLife is driven by a mission to deliver innovative treatment options to patients suffering from heart valve diseases.
  • DMC Biotechnologies — Transforming How the World Makes Chemicals
  • Delft Advanced Biorenewables — We enable the bio-economy by improving the productivity of fermentations with our in-situ product recovery (ISPR) technology.
Show all investments...

MVM Life Science Partners
VC Fund · London, England, United Kingdom · 1 investments in Finland Medical startups

MVM invests in innovative healthcare companies. Our active portfolio companies are transforming the delivery of healthcare by enabling higher quality, cost-effective care in large, global markets.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series B, Series C, Venture - Series Unknown
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 81
  • Round size: Series B $7M–$42M; Series C $12M–$45M; Venture - Series Unknown $11M–$68M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: Likely actively investing — fresh fund, raised $10M in 2025

Portfolio highlights

  • VitalConnect — VitalConnect develops wearable biosensor technology designed for wireless patient monitoring. It leverages extensive expertise in biomedical engineering, data analytics, chip design, and mobile and cloud software to create technology that supports decision-making paradigms. The company's products are designed for inpatient and outpatientsettings, such as hospital monitoring, post-discharge care, cardiac monitoring, and pharmaceutical solutions.
  • Beacon Endoscopic — Beacon Endoscopic (BE) is a Boston based medical device company innovating in existing interventional endoscopic procedures and developing next generation devices to change the paradigm of surgery
  • Vantia Therapeutics — Vantia Therapeutics is an emerging pharmaceutical company developing novel, small molecule drugs targeting large areas of unmet medical need. Its strong clinical pipeline includes VA106483 for nocturia and VA111913 for dysmenorrhoea, which directly target indications that together affect many millions of people, are poorly treated and representbillion dollar markets. Vantia's strategy is to develop its proprietary drug candidates through Phase II clinical testing and then commercialise through partnerships. The Company was founded in 2008 and is backed by specialist life science investors Novo A/S, SV Life Sciences and MVM Life Science Partners.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
HTGF (High-Tech Gruenderfonds)
VC Fund · Bonn, Nordrhein-Westfalen, Germany · 1 investments in Finland Medical startups

High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in various sectors.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Germany, Switzerland, United States

Investor stats

  • Total investments: 851
  • Round size: Seed $680k–$6.5M; Series A $3M–$31M; Venture - Series Unknown $911k–$12M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely still investing — raised $515M in 2022

Portfolio highlights

  • Extoll — EXTOLL, a leader in high-speed, ultra-low power SerDes and Chiplet connectivity, offers semiconductor IP with the smallest footprints and highest PPA. Serving global ASIC, SoC, and Chiplet markets, our portfolio includes tailored NoC (Network-on-Chip) and Die-to-Die solutions. EXTOLL drives innovation, enabling successful migration into the Chiplet Age.
  • Selfapy — Selfapy offers a therapy support tool that helps recognize negative patterns of thought and train new behavior. Selfapy is your guided, self-help online course against depression with a personal psychologist as a companion.
  • BlueID GmbH — Smart locks for professionals. BlueID delivers flexible, secure and convenient smart locks for all doors in and around your office.
Show all investments...

Korpun Siemen
VC Fund · Oulu, Oulu, Finland · 1 investments in Finland Medical startups

Korpun Siemen is backed by 33 investors who have combined their initial investment activities and have extensive experience in start-up, growth and family businesses in various industries. The company includes active angel investors, entrepreneurs in growth companies and investors who have already exited their companies.

Show more...

Investment focus

  • Industry: Software, Marketing, Information Technology
  • Stage:Seed, Angel
  • Geography: Finland

Investor stats

  • Total investments: 10
  • Round size: Seed $480k–$1.3M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Mobal — It is time to get your Business Profiles in shape. Meet your customers where they are and stand out where it matters most.
  • Remod — Remod provides holistic IT surveys, backup services, cyber control, functional programming, data processing, incident response, secure systems, network design, and proof of concept development.
  • Builderhead — Builderhead is an easy-to-use construction management software that helps owners, developers and general contractors complete construction projects on time and within budget.
Show all investments...

Metaplanet
VC Fund · Tallinn, Harjumaa, Estonia · 1 investments in Finland Medical startups

an early-stage investment firm making long-term bets on contrarians and leveraging the knowledge and network across sectors. We back mission-driven founders working on positively disruptive deep technologies.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Machine Learning
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Estonia

Investor stats

  • Total investments: 110
  • Round size: Seed $1.7M–$12M; Series A $5.9M–$40M; Series B $23M–$62M
  • Lead/follow: 13% lead, 87% follow
  • Last fund: Likely actively investing — fresh fund, raised $69M in 2025

Portfolio highlights

  • Kopra Bio — Cancer immunotherapy that turns cancer cells into biofactories minting their own destruction.
  • Inherent — Living within the experiment.
  • Lightyear — Lightyear is a simple and approachable way to invest your money globally without unnecessary barriers and fees.
Show all investments...

Jukka Tapaninen
Angel · 1 investments in Finland Medical startups

Jukka Tapaninen is an experienced IT business executive and a board member at Fimmic. Jukka also holds board positions at weVision, Addoro Ab, Findity and MeshWorks Wireless Oy.Jukka has a strong background in the IT industry on managing companies and business units globally. His leadership experience, from large companies like SAP and HP, aswell as from strong midsize companies has given him industry knowledge and excellent network within the strategic ecosystem and major customers. Jukka has experience in working in the United States, Singapore and multiple locations in Europe that have given him a good understanding on how business is done in different parts of the world.Jukka holds a M.Sc. degree from the Helsinki School of Economics.

Show more...

Investment focus

  • Industry: Medical, Software, Education
  • Stage:Seed
  • Geography: Finland

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Aiforia — Aiforia provides software and services for pathologists, scientists and healthcare professionals to use artificial intelligence for image analysis.
Show all investments...

Way to Wellville
VC Fund · Astoria, Oregon, United States · 1 investments in Finland Medical startups

Wellville is a 10-year national nonprofit project to achieve equitable wellbeing. We support the efforts of The Wellville 5: Five US communities.

Show more...

Investment focus

  • Industry: Software, Medical, Health Care
  • Stage:Series B, Venture - Series Unknown, Series A
  • Geography: United States, Finland

Investor stats

  • Total investments: 7
  • Round size: Series B $12M–$15M; Venture - Series Unknown $1.2M–$3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Upbeat — Upbeat will be your PR partner for a fraction of the cost of traditional PR firms. Through our software and expertise, we will help you develop a media
  • Trimian — Startup based in Menlo Park, focusing on mobile apps. The name comes from 'tri-simian', referring to the three wise monkeys.
  • Big Health — Our mission is to help millions back to good mental health. Our digital therapeutics are safe and effective non-drug alternatives for mental health.
Show all investments...

Sunstone Life Science Ventures
VC Fund · Copenhagen, Hovedstaden, Denmark · 1 investments in Finland Medical startups

Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Denmark, Sweden, Switzerland

Investor stats

  • Total investments: 63
  • Round size: Series A $5.5M–$61M; Series B $9.5M–$58M; Series C $4.1M–$63M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: May invest from a new fund soon — raised $92M in 2019

Portfolio highlights

  • Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
  • Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
  • TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Show all investments...

Visionplus
VC Fund · Helsinki, Southern Finland, Finland · 1 investments in Finland Medical startups

WE HELP YOU TO GROW FASTER!

Show more...

Investment focus

  • Industry: Software, Information Technology, Internet
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: Finland, United States, United Kingdom

Investor stats

  • Total investments: 76
  • Round size: Seed $87k–$1.3M; Series A $2M–$14M; Venture - Series Unknown $100k–$4M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • Pebble — Meet Pebble Flow: a 100% electric RV with active towing, auto-hitching and infinite off-grid power via our Extended Solar upgrade. Reserve now.
  • LiveMusicStage — We're a live music venue online. We let you to actually take part in the shows and interact with the bands while they're playing. You're always in the front row
  • BetterDoctor — Our provider network software solutions & services provide unmatched tools & insights for you. Discover how you can measure, manage, monitor & model.
Show all investments...

Debiopharm Innovation Fund
VC Fund · Lausanne, Vaud, Switzerland · 1 investments in Finland Medical startups

Debiopharm invests in Smart Data & Digital Health companies developing technologies that are applicable in the areas of oncology or infectious diseases

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Series A, Seed, Pre-Seed
  • Geography: United States, Switzerland, France

Investor stats

  • Total investments: 49
  • Round size: Seed $943k–$6M; Pre-Seed $317k–$1.7M; Series A $4M–$25M
  • Lead/follow: 55% lead, 45% follow

Portfolio highlights

  • Octozi — AI agents that accelerate clinical development. Automate data cleaning, review, reconciliation, and reporting across your trials.
  • ModernVivo — Search millions of preclinical papers and extract experimental conditions in minutes. Design faster, better-powered in vivo studies with deterministic results.
  • WhiteLab Genomics — Discover WhiteLab Genomics, where AI meets biology to revolutionize genomic medicine. Our innovative platform optimizes drug design for greater safety and efficacy.
Show all investments...

SHS Capital
VC Fund · Tübingen, Baden-Wurttemberg, Germany · 1 investments in Finland Medical startups

SHS is an independent private equity company. Their focus is on investments in the MedTech, Life Sciences, Diagnostics, and Digital Health sectors.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Venture - Series Unknown, Series B, Series C
  • Geography: Germany, Switzerland, France

Investor stats

  • Total investments: 44
  • Round size: Series B $5.3M–$60M; Series C $6.6M–$14M; Venture - Series Unknown $6.6M–$21M
  • Lead/follow: 57% lead, 43% follow
  • Last fund: Likely still investing — raised $273M in 2022

Portfolio highlights

  • Arzneimittelwerk Warngau — Unsere Schwerpunkte Karriere bei AMW
  • ROTOP — ROTOP is a pharmaceutical company. They manufacture cGMP-compliant radiopharmaceuticals for diagnostics and therapy in the fields of nuclear medicine. They provide API/precursor synthesis, analysis kit development, project management, full regulatory support spect, PET, quality control, and therapy services. Their customers contact throughemail and phone number.
  • Salvia BioElectronics — Our mission is to give people with migraine a better life. As a pioneer in the field of medical devices, Salvia BioElectronics is passionately committed to empowering people with migraine to reclaim their lives.
Show all investments...

Inveni Capital
VC Fund · Helsinki, Southern Finland, Finland · 1 investments in Finland Medical startups

Inveni Capital is a venture capital management company focused on investments in early to growth stage life sciences companies.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Venture - Series Unknown
  • Geography: Finland, United Kingdom

Investor stats

  • Total investments: 2
  • Round size: Venture - Series Unknown $3.4M–$11M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • BioSilta — BioSilta Ltd. is a privately-held company that utilizes its unique, proprietary EnBase® technology platform to develop innovative, reagent-based EnPresso® growth systems. When compared to conventional growth media, EnPresso growth systems significantly increase the yield of high quality biomolecules from microbial cultures.
  • Onbone — Woodcast uudetkasinot esittelee ajankohtaiset ja huolellisesti valitut uudet nettikasinot, tarjoten suomalaisille pelaajille tuoreita pelimahdollisuuksia, innovatiivisia ominaisuuksia ja luotettavan pelikokemuksen.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Athensmed
VC Fund · 1 investments in Finland Medical startups

Athensmed Oy

Show more...

Investment focus

  • Industry: Health Care, Health Diagnostics, Medical
  • Stage:Seed, Series A
  • Geography: Finland, Switzerland

Investor stats

  • Total investments: 5
  • Round size: Seed $1.1M–$4.3M
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • Biospectal — Measure and track blood pressure with only your phone camera and fingertip. With OptIBP, you can keep a diary of blood pressure, share BP, and take control of your heart health.
  • Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
  • Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
Show all investments...

Ascend Capital Partners
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 1 investments in Finland Medical startups

Founded by two Wall Street professionals in 2002 with the goal of making companies successful by helping them raise capital and improve their management standards. This was done by taking an active role in running these companies (at the Board level and operationally) and helping to secure strategic partnerships.Over USD 100 million in assetsgenerated from successful investments in China, and more recently in Europe. All invested funds come from our partners; no 3rd party money is managed. Since the partners are investing their own capital, they are dedicated to making their investments successful.Led by Monita Mo, one of the founders and a serial entrepreneur. Our partners have decades of experience across a wide range of industries and geographical regions. All investment partners have done business in Asia and bring an extensive network of contacts for our investments. Additionally, they have started, managed, and sold businesses and understand the challenges involved.See the need to share more developed technology to other markets, especially in China, where growth opportunities may be greater. That is why we are currently focusing on companies in Europe and other developed markets that have unique technologies that can be commercialized in their home markets, Asia, and the US.

Show more...

Investment focus

  • Industry: Health Care, Software, Medical Device
  • Stage:Series A, Seed, Series B
  • Geography: Finland, Israel, Austria

Investor stats

  • Total investments: 19
  • Round size: Seed $1.5M–$9.3M; Series A $2.4M–$12M
  • Lead/follow: 53% lead, 47% follow

Portfolio highlights

  • DriveU.auto — Transform existing terminal tractors into autonomous vehicles. Fast ROI. Continuous operation in mixed traffic.
  • Pionix — PIONIX develops EVerest, a fully featured commercial open source SW platform for charging stations. With our open platform, we will provide a broad ecosystem for EV charging that can be easily extended by the open-source community and utilized by any commercial party.PIONIX as main developer of the EVerest ecosystem offers integration andsoftware update services, cloud operations and productivity & security enhancements as subscriptions.
  • piur imaging — PIUR´s tomographic ultrasound solutions turn any standard ultrasound system into a tomographic 3D imaging device, bridging the gap between 2D ultrasound and regular tomographic imaging modalities. With any conventional 2D ultrasound transducer, high-resolution tomographic images can be generated and stored as quantifiable volumes, enabling true AIpost-processing for efficient diagnostics. Current focus is on thyroid imaging where AI algorithms allow doctors a fast and objective analysis and classification of thyroid nodules.
Show all investments...

XR Invest
VC Fund · 1 investments in Finland Medical startups

XR Invest is an investment firm focused on medtech and digital health early-stage start-ups.

Show more...

Investment focus

  • Industry: Medical Device, Sensor, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Finland, United States

Investor stats

  • Total investments: 4
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Augmedics — Augmedics is a provider of augmented reality (AR) surgical image guidance solutions. Augmedics seeks to improve healthcare by developing cutting-edge technologies that will revolutionize surgical treatment. The company’s first product, the xvision-spine (XVS) system, is an augmented-reality surgical navigation system designed to allow surgeons tosee and navigate inside a patient’s body during complex procedures.
  • Synoste — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
Show all investments...

Ali Omar
Angel · Helsinki, Southern Finland, Finland · 1 investments in Finland Medical startups

Ali Omar is a Member of the Finnish Business Angels Network. He attended Aalto University and the University of Oulu.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Pre-Seed, Angel
  • Geography: Finland, United States, Estonia

Investor stats

  • Total investments: 69
  • Round size: Seed $227k–$2.2M; Angel $57k–$1.7M; Pre-Seed $168k–$734k
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Themo — Themo's innovation is an algorithm that optimizes the price of exchange electricity and the consumption of electricity. Themo offers an easy and environmentally friendly way to save on electricity consumed by heating.
  • GoalProfit — GoalProfit is the world’s first low code retail optimization platform empowering retailers to build customized intelligence applications. It was founded by former IBM executives, Maxim Morozov and Oleg Sidorkin. GoalProfit is on a mission to make big data solutions available for all retailers and help them to survive in a new post-covid reality.
  • Retailgrid — Retail pricing software that lifts margin, not workload. Competitor price monitoring every 4 hours, price optimization and plain-English rules in a Grid your team already knows. Free pricing audit.
Show all investments...

Noaber
VC Fund · Lunteren, Gelderland, The Netherlands · 1 investments in Finland Medical startups

Noaber Ventures invests in initiatives that bring social transformations using information technology.

Show more...

Investment focus

  • Industry: Health Care, Medical, Fitness
  • Stage:Seed, Series A, Pre-Seed
  • Geography: The Netherlands, Israel, Germany

Investor stats

  • Total investments: 20
  • Round size: Seed $423k–$6.3M; Series A $3M–$20M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Plasmacure — Plasmacure develops innovative plasma technology for wound care. Discover how cold plasma is transforming the treatment of chronic wounds.
  • Mirantus Health — Mirantus is building a distributed healthcare provider to improve access to care for underserved patients. Through healthcare services (Mirantus Care) and cloud-solutions (Mirantus OS), Mirantus empowers doctors to efficiently treat patients who were difficult to reach before. This improves healthcare access for patients, allows physicians to earnmore, while saving payors billions in downstream costs. Mirantus is on a mission to get every specialist physician in Europe to participate in distributed healthcare, to improve healthcare access for 100M+ underserved patients.
  • Alba Health — Discover your baby's gut health & microbiome for the best start in life.
Show all investments...

Cor Group
VC Fund · Oulu, Oulu, Finland · 1 investments in Finland Medical startups

Cor Group management consulting firm serving Psychological, Educational, and Behavioral Services.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Finland

Investor stats

  • Total investments: 6
  • Round size: Seed $2.3M–$8.7M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Gosta Labs — Focus on care
  • Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
  • Nightingale Health — The most advanced health check for the health industry.
Show all investments...

Marten Mickos
Angel · San Francisco, California, United States · 1 investments in Finland Medical startups

Marten Mickos is the CEO of HackerOne, Inc. the leading vulnerability coordination and bug bounty platform. Previously Marten was the CEO of Eucalyptus Systems, acquired by Hewlett-Packard where he served as head of the cloud business. As the CEO of MySQL AB from 2001 to 2008, Marten grew that company from a garage start-up to the second largest open source company in the world. Marten holds a M.Sc. in technical physics from Helsinki University of Technology in his native Finland.

Show more...

Investment focus

  • Industry: Software, Enterprise Software, Internet
  • Stage:Seed, Series A, Convertible Note
  • Geography: Finland, United States, Sweden

Investor stats

  • Total investments: 16
  • Round size: Seed $550k–$4.5M; Series A $5M–$10M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Tangled — The next-generation social coding platform.
  • Pandatron — With clients like SAP, Universal Pictures & Skanska, Pandatron is a startup that supports change management. We do it by scaling AI-driven coaching 1-on-1s to every employee, which also allows us to measure change.
  • Coherence Quantum — Coherence Quantum is a quantum hardware company that creates integrated cryogenic signaling and control platforms designed for solid-state quantum computers.
Show all investments...

Hadean Ventures
VC Fund · Oslo, Oslo, Norway · 1 investments in Finland Medical startups

Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across the region

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: Sweden, Norway, Austria

Investor stats

  • Total investments: 36
  • Round size: Series A $4.2M–$79M; Series B $4.5M–$75M; Venture - Series Unknown $2M–$29M
  • Lead/follow: 50% lead, 50% follow
  • Last fund: May invest from a new fund soon — raised $168M in 2021

Portfolio highlights

  • Oncoinvent — Oncoinvent AS designs and develops cancer treatments by applying known physical and chemical principles of selected novel materials in new ways in order to maximize their medical benefit while minimizing potential safety concerns.
  • Kasvu Therapeutics — Kasvu develops first and best-in-class small molecule neuroplastogens for diseases where neuronal connectivity is altered
  • TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Show all investments...

Unifund
VC Fund · 1 investments in Finland Medical startups

Unifund Jyväskylä Ltd is to support the start-up of research-based businesses.

Show more...

Investment focus

  • Industry: Software, Collaboration, Management Consulting
  • Geography: Finland

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Humap — Howspace is an AI-powered online platform that brings digital collaboration and social learning to the forefront of your process & development initiatives.
  • PrecisionPhage — PrecisionPhage is a biotech business that specializes on bacteriophage technologies.
Show all investments...

Nordea
VC Fund · Helsinki, Southern Finland, Finland · 1 investments in Finland Medical startups

Nordea Bank is Denmark's second-largest bank and counts every fourth Dane among its customers. Through their nationwide network of some 340 branch offices and a broad range of self-service facilities, they are able to offer you a full scale of financial products and services, including Netbank, Online Investment, telephone banking and cashdispensers.

Show more...

Investment focus

  • Industry: FinTech, Financial Services, Banking
  • Stage:Debt Financing, Seed
  • Geography: Finland, Sweden, Norway

Investor stats

  • Total investments: 23
  • Lead/follow: no public data

Portfolio highlights

  • Tibber — Tibber is a digital electricity supplier that offers smart solutions to minimize their customers’ consumption and costs. Its vision is to make sustainable energy consumption simple and affordable for all households. Tibber's mission is to reduce the residential electricity consumption for European households by 20 %. Founded in Norway andSweden in 2016, the company has expanded its offer to Sweden and Germany where it powers hundreds of thousands of homes. Tibber replaces traditional utilities with smart technology, supplying its customers with renewable energy at fair and transparent prices. In addition, its app provides real-time analytics into energy usage, and pairs with a variety of smart home devices to reduce electricity consumption at home. The company sells tech-gadgets in their online store and recently was licensed to balance the main power grid in Sweden with EVs.
  • Statzon — Make data-driven plans & faster decisions with a simple access to +1M datasets & market reports about 8,000 topics from +200 trusted data providers.
  • Get It Done Now — GIDN is a Nigerian Fintech Company targeting medium and low income population for Loans and Financial products. GIDN has in addition a cashless, mobile based community marketplace, with more than 5k members, and aims to regulate the informal economy and facilitate the purchase of Services and Digital Products.
Show all investments...

Medical Investor funding in Finland at a glance

Stats across 135 deals from 131 investors.

131
investors
in Finland Medical startups
135
deals
in Finland Medical startups
$2.1M
median round
in Finland Medical startups
46%
lead investors
lead at least one round
27%
Seed
most common funding stage
83/17
VC / Angel
share of investor count

Access all 131 investors in Finland Medical startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Medical Investors in Finland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 131 investors investing in Finland Medical startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists